GAITHERSBURG, Md.–(BUSINESS WIRE)–GeneDx Research Demonstrates Medical Actionability of Exome and Genome Sequencing Results in Large Real-World Study of More Than 300,000 Patients
GAITHERSBURG, Md.–(BUSINESS WIRE)–GeneDx Research Demonstrates Medical Actionability of Exome and Genome Sequencing Results in Large Real-World Study of More Than 300,000 Patients